Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Retrospective Cohort Study Evaluating Outcomes of Higher Risk MDS Treated with Hypomethylating Agents with or without Venetoclax Using International Working Group 2023 Response Criteria

Mihir Shukla, Chinyere Okpara, Elaine Xiang, Maher Abdul Hay, Shella Saint Fleur-Lominy, Jun Han Choi

Blood (2024) 144 (Supplement 1): 4602.

https://doi.org/10.1182/blood-2024-206504

Published: 2024

Journal Articles

Artificial Intelligence Versus Expert Physician Assessments of Real-World Hematology Cases: Implications for Clinical Practice

Olivia Main, Matthew Struck, John L Vaughn, Jingmei Hsu, Mohammad Abu Zaid, Shella Saint Fleur-Lominy, Marc J Braunstein

Blood (2024) 144 (Supplement 1): 7523.

https://doi.org/10.1182/blood-2024-211003

Published: 2024

Journal Articles

Assessing the Safety of Discharging Patients Receiving High-Dose Methotrexate with Levels Greater Than 0.1 Umol/L

Elaine Xiang, Jamie Chin, Jonathan Weltz, Aaron Sango, Meredith Akerman, Michael L. Grossbard, Shella Saint Fleur-Lominy

Blood (2022) 140 (Supplement 1): 10806–10807.

https://doi.org/10.1182/blood-2022-167207

Published: 2022

Journal Articles

Evaluating the Safety of Outpatient Ramp up of Venetoclax in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Elaine Xiang, Frank Cirrone, Jamie Chin, Meredith Akerman, Shella Saint Fleur-Lominy, Maher Abdul Hay

Blood (2021) 138 (Supplement 1): 2311.

https://doi.org/10.1182/blood-2021-145057

Published: 2021

Journal Articles

Pegasperagase Toxicity in Adult Patients with Acute Lymphoblastic Leukemia: A Single Center Experience Comparing Patients Older and Younger Than 35 Years of Age

Jun H Choi, MD, Jacques Azzi, MD, Tsivia Hochman, MS, Mary Lynn R. Nierodzik, MD, Shella Saint Fleur-Lominy, MD PhD, Maher Abdul Hay, MD

Blood (2019) 134 (Supplement_1): 5067.

https://doi.org/10.1182/blood-2019-129041

Published: 2019

Journal Articles

NSD2 Mutations in Pediatric ALL Leads to a Distinct Gene Expression Profile and Epigenetic Landscape That Is Cell Context Specific

Joanna Pierro, DO, Jason Saliba, PhD, Nikki Ann Evensen, PhD BS, William L. Carroll, MD, Gunjan Sethia, MS, Shella Saint Fleur-Lominy, MD PhD

Blood (2018) 132 (Supplement 1): 3905.

https://doi.org/10.1182/blood-2018-99-118535

Published: 2018

Journal Articles

Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation

Jacques Azzi, MD, Frank Cirrone, PharmD, Maher Abdul Hay, MD, David Kaminetzky, MD, Kenneth B. Hymes, MD, Maxim Kreditor, MD, Ahmad-Samer Al-Homsi, MD, Michael L. Grossbard, MD, Catherine Diefenbach, MD, Tibor Moskovits, MD, Shella Saint Fleur-Lominy, MD PhD, Bruce G. Raphael, MD, Raoul Tibes, MD PhD

Blood (2018) 132 (Supplement 1): 5216.

https://doi.org/10.1182/blood-2018-99-117314

Published: 2018

Journal Articles

The Role of MMSET E1099K Mutation in Gene Dysregulation, Drug Resistance and Clonogenicity in Acute B-Lymphoblastic Leukemia

Joanna Pierro, DO, Jason Saliba, PhD, Nikki Ann Evensen, PhD BS, Yixiao Gong, Shella Saint Fleur-Lominy, MDPhD, William L. Carroll, MD

Blood (2017) 130 (Supplement 1): 2474.

https://doi.org/10.1182/blood.V130.Suppl_1.2474.2474

Published: 2017

Journal Articles

Genomic and Epigenetic Effects of DNA Methyltransferase Inhibition in Acute Lymphoblastic Leukemia

Shella Saint Fleur-Lominy, MDPhD, Teena Bhatla, MD, Stephen Kelly, MS, Varshini Vasudevaraja, MS, Aristotelis Tsirigos, PhD, William L. Carroll, MD

Blood (2017) 130 (Supplement 1): 2479.

https://doi.org/10.1182/blood.V130.Suppl_1.2479.2479

Published: 2017

Journal Articles

Crac Channel Deletion in Leukemic Cells Delays Progression of Leukemia and Prolongs Survival of Mice with Notch-1-Induced T-Cell Acute Lymphoblastic Leukemia

Shella Saint Fleur-Lominy, MD PhD, Mate Maus, PhD, Stefan Feske, MD

Blood (2015) 126 (23): 1433.

https://doi.org/10.1182/blood.V126.23.1433.1433

Published: 2015

Journal Articles

Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon

Shella Saint Fleur, Akemi Hoshino, Kimie Kondo, Takeshi Egawa, Hodaka Fujii

Blood (2009) 114 (7): 1355–1365.

https://doi.org/10.1182/blood-2008-11-189118

Published: 2009

Includes: Supplemental data

NARROW

A Retrospective Cohort Study Evaluating Outcomes of Higher Risk MDS Treated with Hypomethylating Agents with or without Venetoclax Using International Working Group 2023 Response Criteria

Artificial Intelligence Versus Expert Physician Assessments of Real-World Hematology Cases: Implications for Clinical Practice

Assessing the Safety of Discharging Patients Receiving High-Dose Methotrexate with Levels Greater Than 0.1 Umol/L

Evaluating the Safety of Outpatient Ramp up of Venetoclax in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Pegasperagase Toxicity in Adult Patients with Acute Lymphoblastic Leukemia: A Single Center Experience Comparing Patients Older and Younger Than 35 Years of Age

NSD2 Mutations in Pediatric ALL Leads to a Distinct Gene Expression Profile and Epigenetic Landscape That Is Cell Context Specific

Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation

The Role of MMSET E1099K Mutation in Gene Dysregulation, Drug Resistance and Clonogenicity in Acute B-Lymphoblastic Leukemia

Genomic and Epigenetic Effects of DNA Methyltransferase Inhibition in Acute Lymphoblastic Leukemia

Crac Channel Deletion in Leukemic Cells Delays Progression of Leukemia and Prolongs Survival of Mice with Notch-1-Induced T-Cell Acute Lymphoblastic Leukemia

Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only